Early adopters of GLP-1 drugs have now lost the weight and are beginning to transition off them. How can F&B support the ...
Researchers quantified prebiotic levels in 35 common foods and estimated daily intake in Italians, finding cereal products ...
Gasherbrum Bio Inc. has described glucagon-like peptide 1 receptor (GLP-1R) agonists reported to be useful for the treatment of type 2 diabetes, dyslipidemia, schizophrenia, hypertension, obesity, ...
Chilean foodtech firm NotCo says it expects to be profitable in Chile, Argentina, Colombia, and Peru in Q2, 2025.
GLP-1 medications are making headlines in medical weight loss—learn how they impact overall health and chronic disease ...
Many employers are facing challenges in incorporating high-cost GLP-1 medications, such as Mounjaro, Ozempic, Rybelsus, Trulicity, and Wegovy, ...
At STAT's Breakthrough Summit East, the CEOs of Ro and Included Health said the the U.S. health care system poses obstacles ...
There are early and suggestive data that GLP-1 drugs reduce alcohol cravings. A large cohort of people with alcohol use ...
Despite a crowded GLP-1 drug development field, Structure's oral small molecule approach and strong financial position offer ...
GLP-1 RA use is associated with better graft and patient survival among kidney transplant recipients with diabetes.
We recently published a list of Jim Cramer Was Talking About These 10 Stocks Amid Tariff Chaos. In this article, we are going to take a look at where The Campbell’s Company (NASDAQ:CPB) stands against ...
Last week, we heard about how beverage giant PepsiCo (PEP) was looking to pick up the probiotic soft drink brand Poppi in a bid to keep its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results